Document vVYDR5d9rbwBgmq5QdZ05ZErY

ALLENTOWN, PENNSYLVANIA 18105 13 October 1975 OCT 1 i 1975 Dr. T. 3. Torknlson Dow Chemical Comany Health S Fnvir. ''osearcc ODD" D iiVin midland, Michinan Dear Ted: You will recall that when Dr. Tamburro Made his presentation to the Research Coordinators at the MCA on 8 September 1975 under his Medical Surveillance Program oe listed the following: 1. Diocbenil cal 2. Dsdiolor,/ 3. Pulmonary 4. Pari lac 5. history and Physical . '- ?: ` - JV , It is mv opinion that most companies are not makirui a cardiac examina tion under their current medical surveillance of those people exposed to vinyl chloride. I think it pertinent that vou cr perhaps better the MCA program j are done. Sincerely you AS I 00021968 ALLENTOWN, PENNSYLVANIA 18105 M Jctobor 1975 OCT 2 0 1975 Subject Jin/1 Chi or; in Sweden an! on t of excellence. You will recall Ihat 'lick Wncalor at our September meting mentioned the O^C shewed a-.ionc fabricators accordin'] to my notes diseases of circulatory sysfcn to be higher than expected as 1 ,S7o observed with expected 1,444. You may also remember that bury Johnson thought these differences '/eve significant. The Kera'-lord repo r; lends further evidence that we should 1 finedlately contact all nenher comoanies of the :*CA vinyl Cnlcrids Program. Hy ` question of yesterday was ' / ther any cardiac examinations are made and v,y question of toby is /hat have been the findings, If so done. With best regards. Sincerely yours. ASI 00021969